Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-FR Version v8-EN
Language French English
Date Updated 2019-04-18 2018-11-24
Drug Identification Number 00261998 00261998
Brand name SODIUM BICARBONATE INJECTION USP SODIUM BICARBONATE INJECTION USP
Common or Proper name Sodium Bicarbonate Injection USP Sodium Bicarbonate Injection USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients SODIUM BICARBONATE SODIUM BICARBONATE
Strength(s) 84MG 84MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 50mL LifeShield Syringes 10 x 50mL LifeShield Syringes
ATC code B05XA B05XA
ATC description I.V. SOLUTION ADDITIVES I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-11-23
Actual start date 2018-11-27
Estimated end date 2019-05-15
Actual end date 2019-04-17
Shortage status Resolved Actual shortage
Company comments Pfizer Canada is experiencing supply constraints on Sodium Bicarbonate LifeShield syringes in the 50mL format. Available supply will be managed through measured national allocation to wholesalers.
Health Canada comments